comparemela.com

Latest Breaking News On - Insugen insulin recombinant human formulations - Page 1 : comparemela.com

Duopharma s 4Q net profit slips on higher cost challenges, declares 1 8 sen dividend

Duopharma Biotech Bhd’s net profit for the fourth quarter ended Dec 31, 2021 (4QFY21) slipped 2.94% to RM15.72 million from RM16.19 million a year ago because of higher costs.

Duopharma posts net profit of RM15 7mil in 4Q21

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit fell almost 3% to RM15.71mil in the fourth quarter ended Dec 31, 2021 (4Q21) against RM16.19mil a year ago.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.